NP137 Clinical and Biological Activities Assessment in Patients With Advanced/Metastatic Solid Tumors Treated by Standard Anti PD-1/PD-L1 Immunotherapies

NCT05605496 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumors
Metastatic Solid Tumors

Interventions

DRUG: NP137
DRUG: anti-PD-1/PD-L1

Sponsor

Centre Leon Berard

Collaborators

[object Object]